EUVIMEDEUVIMED entdecken
Crossref

Metabolomics Reveals Shugan Formula Attenuates Anti‐Tuberculosis Drug‐Induced Liver Injury via Multi‐Pathway Metabolic Reprogramming in Rats

Liqin Liu, Ying Wang iD, Chuqing Du, Shujing Wang, Xu Hu iD, Hongyan Wang, Yi Tao iD

Biomedical Chromatography · 2026-12 · 40 (12)

DOI: 10.1002/bmc.70646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 26.10.2026. Verfasst von Liqin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Red Cross Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Antitubercular Agents, Metabolome, Plant Extracts. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Hangzhou Biomedical and Health Industry Development Support Technology Special Project, Research Project of Zhejiang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shugan Formula (SGF) shows clinical hepatoprotective effects, but its mechanism against anti‐tuberculosis drug‐induced liver injury (ATB‐DILI) remains unclear. This study employed LC–MS/MS‐based metabolomics to investigate SGF's protective effects in rats. ATB‐DILI was induced by oral isoniazid and rifampicin (100 mg·kg −1 each) for 14 days. During modeling, the rats in the treated groups received low, medium, or high doses of SGF via oral gavage, whereas the PC group was administered obeticholic acid. Serum biomarkers (ALT, AST, IL‐6, IL‐10, and TNF‐α), hepatic oxidative stress markers (MDA, SOD, GST, and GSH‐Px), liver histopathology, and serum metabolomics were assessed. SGF treatment significantly reduced serum ALT, AST, TNF‐α, and IL‐6 levels, decreased hepatic MDA and GST levels, and increased SOD and GSH‐Px activities. Metabolomics revealed that SGF attenuated metabolic perturbations induced by liver injury, with the high‐dose group being most effective. Key pathways involved amino acid metabolism, bile acid metabolism, and glycerophospholipid metabolism. This study provides scientific evidence for SGF in preventing and treating ATB‐DILI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryAntitubercular AgentsMetabolomePlant ExtractsAnimalsRatsMaleMetabolomicsLiverRats, Sprague-DawleyBiomarkersTandem Mass SpectrometryOxidative StressMetabolic Networks and PathwaysIsoniazidChromatography, LiquidRifampin

Stichwörter der Autor:innen

Shugan Formulaanti‐tuberculosis drugsliver injurymetabolomics

Substanzen

Antitubercular AgentsBiomarkersIsoniazidPlant ExtractsRifampin

Autor:innen und Institutionen

  • Hangzhou Red Cross Hospital, Hangzhou, China.
  • Zhejiang Int'l Medicine Materials Co., Ltd, Wenzhou, China.
  • Tongde Hospital of Zhejiang Province, Hangzhou, China.
  • College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China.

ORCID-Profile: Ying Wang, Xu Hu, Yi Tao

Förderung

  • Hangzhou Biomedical and Health Industry Development Support Technology Special Project
  • Research Project of Zhejiang University

Zitieren

APA

Liu, L., Wang, Y., Du, C., Wang, S., Hu, X., Wang, H., & Tao, Y. (2026). Metabolomics Reveals Shugan Formula Attenuates Anti‐Tuberculosis Drug‐Induced Liver Injury via Multi‐Pathway Metabolic Reprogramming in Rats. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70646

Vancouver

Liu L, Wang Y, Du C, Wang S, Hu X, Wang H, et al. Metabolomics Reveals Shugan Formula Attenuates Anti‐Tuberculosis Drug‐Induced Liver Injury via Multi‐Pathway Metabolic Reprogramming in Rats. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70646

BibTeX
@article{Liu2026,
  author = {Liu, Liqin and Wang, Ying and Du, Chuqing and Wang, Shujing and Hu, Xu and Wang, Hongyan and Tao, Yi},
  title = {Metabolomics Reveals Shugan Formula Attenuates Anti‐Tuberculosis Drug‐Induced Liver Injury via Multi‐Pathway Metabolic Reprogramming in Rats},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {12},
  doi = {10.1002/bmc.70646}
}
Kostenlos starten →